GregoryVidalMD

PubMed

• 1 citations
  First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
  Schmid, P., Turner, N., Barrios, C., Isakoff, S., Kim, S., Sablin, M., Saji, S., Savas, P., Vidal, G., Oliveira, M., O'Shaughnessy, J., Italiano, A., Espinosa, E., Bon...> ;Clinical Cancer Research. 2024 Feb 16
• Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in...
  Jain, N., Fisher, A., Sheinson, D., Lofgren, K., Ma, E., Yu, E., Comment, L., Sincan, M., Martin, R., Zuniga, R., Vidal, G., Miksad, R., Daniel, D.> ;JCO Oncology Practice. 2024 Mar 1
• Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-st...
  Anderson, J., Paladino, A., Blue, R., Dangerfield, D., Eggly, S., Martin, M., Graetz, I., Schwartzberg, L., Vidal, G.> ;Journal of Cancer Survivorship. 2023 Dec 19
• Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research.
  Vidal, G., Chalela, P., Curry, A., El-Rayes, B., Halmos, B., Herrera, A., Kapoor, K., Kaur, S., Mahadevan, D., Mesa, R., Ramirez, A., Sleckman, B., Wagner, A., Bhagat,...> ;Contemporary Clinical Trials. 2024 Feb 1
• 3 citations
  Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
  Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump, Gregory A Vidal, Virginia F Borges, Peter Kabos, Jennifer R Diamond, Elena Shagisult...> ;NPJ Breast Cancer. 2023 May 20
• 2 citations
  27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
  David L Saltman, Matthew G Varga, Tyler J Nielsen, Nicole S Croteau, Heather M Lockyer, Amit L Jain, Gregory A Vidal, David R Hout, Brock L Schweitzer, Robert S Seitz,...> ;Clinical Lung Cancer. 2023 Mar 1
• 1 citations
  An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer.
  Andrew J Paladino, Kinsey Pebley, Mehmet Kocak, Rebecca A Krukowski, Teresa M Waters, Gregory Vidal, Lee S Schwartzberg, Andrea N Curry, Ilana Graetz> ;BMC Health Services Research. 2022 Nov 23
• 4 citations
  Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial.
  Ilana Graetz, Xin Hu, Andrea N Curry, Andrew Robles, Gregory A Vidal, Lee S Schwartzberg> ;Cancer Medicine. 2023 Mar 1
• Metastatic triple negative breast cancer with NTRK gene fusion on tissue but not on ctDNA molecular profile.
  Nupur Singh, Rishika Singh, Brennan Decker, David Robins, Gregory Vidal> ;BMJ Case Reports. 2022 Oct 12
• 3 citations
  Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor-Positive Breast Cancer.
  Xin Hu, Cameron M Kaplan, Michelle Y Martin, Mark S Walker, Edward Stepanski, Lee S Schwartzberg, Gregory A Vidal, Ilana Graetz> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Feb 6
• 3 citations
  Molecular characterization of ESR1 variants in breast cancer.
  Arielle L Heeke, Andrew Elliott, Rebecca Feldman, Hazel F O'Connor, Paula R Pohlmann, Filipa Lynce, Sandra M Swain, Maria R Nunes, Daniel Magee, Matthew J Oberley, Jef...> ;Breast Cancer Research and Treatment. 2022 Nov 1
• 4 citations
  Characterization of the Metabolome of Breast Tissues from Non-Hispanic Black and Non-Hispanic White Women Reveals Correlations between Microbial Dysbiosis and Enhanced...
  Alana Smith, Xueyuan Cao, Qingqing Gu, Ernestine Kubi Amos-Abanyie, Elizabeth A Tolley, Gregory Vidal, Beverly Lyn-Cook, Athena Starlard-Davenport> ;Cancers. 2022 Aug 23
• 8 citations
  Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events.
  Ari M VanderWalde, Xinhua Yu, Gregory A Vidal, G Gary Tian, Guo, M.> ;Clinical Lung Cancer. 2022 Dec 1
• 10 citations
  Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.
  Xin Hu, Mark S Walker, Edward Stepanski, Cameron M Kaplan, Michelle Y Martin, Gregory A Vidal, Lee S Schwartzberg, Ilana Graetz> ;JAMA Network Open. 2022 Aug 1
• 4 citations
  A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
  Nadia Harbeck, Harold J Burstein, Sara A Hurvitz, Stephen Johnston, Gregory A Vidal> ;Cancer. 2022 Jun 1
• 7 citations
  Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
  Harsha Ranganath, Amit L Jain, Justin R Smith, Julie Ryder, Amina Chaudry, Emily Miller, Felicia Hare, Poojitha Valasareddy, Robert S Seitz, David R Hout, Matthew G Va...> ;BMC Cancer. 2022 Apr 14
• 5 citations
  Social Disparities of Pain and Pain Intensity Among Women Diagnosed With Early Stage Breast Cancer.
  Hyo Young Choi, Ilana Graetz, Arash Shaban-Nejad, Lee Schwartzberg, Gregory Vidal, Robert Lowell Davis, Eun Kyong Shin> ;Frontiers in Oncology. 2022 Jan 1
• Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.
  Gregory A. Vidal, Santosh Gautam, Anna Vlahiotis, Maxine D. Fisher, Sonia Pulgar, Kendra DeBusk> ;Future Oncology. 2021 Nov 10
• 4 citations
  Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy.
  Xin Hu, Puneet Kaur Chehal, Cameron M. Kaplan, Rebecca A. Krukowski, Roy H. Lan, Edward J. Stepanski, Lee S. Schwartzberg, Gregory A. Vidal, Ilana Graetz> ;JAMA Network Open. 2021 Jun 1
• 11 citations
  Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
  Erika Hamilton, Virginia G. Kaklamani, Carla I. Falkson, Gregory A. Vidal, Patrick J. Ward, Monika Patre, Stephen Y. Chui, Jacob Rotmensch, Kushagra Gupta, Luciana Mol...> ;Clinical Breast Cancer. 2021 May 15
• 3 citations
  Development of a Prognostic Factor Index Among Women With HR+/HER2- Metastatic Breast Cancer in a Community Oncology Setting.
  Gregory A. Vidal, Gebra Cuyun Carter, Adrienne M Gilligan, Kim Saverno, Yajun Emily Zhu, Gregory L Price, Angelo DeLuca, Emily Nash Smyth, Sarah Rybowski, Yu-Jing Huan...> ;Clinical Breast Cancer. 2021 Jan 1
• 18 citations
  Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
  Ari M. Vanderwalde, Axel Grothey, Daniel Vaena, Gregory A. Vidal, Adam C. ElNaggar, Gabriella Bufalino, Lee S. Schwartzberg> ;Journal of Personalized Medicine. 2020 Nov 27
• 10 citations
  Remote Oncology Care: Review of Current Technology and Future Directions
  Bradley Alexander McGregor, Gregory A. Vidal, Sumit A. Shah, James D Mitchell, Andrew Eugene Hendifar> ;Cureus. 2020 Aug 31
• 22 citations
  Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway
  Arielle L Heeke, Joanne Xiu, Andrew Elliott, W. Michael Korn, Filipa Lynce, Paula R. Pohlmann, Claudine Isaacs, Sandra M. Swain, Gregory A. Vidal, Lee S. Schwartzberg,...> ;Breast Cancer Research and Treatment. 2020 Aug 10
• 27 citations
  "Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-provider Communication Needs and Preferences among Black and White Women with Early-stage Breast ...
  Janeane N. Anderson, J. Carolyn Graff, Rebecca A. Krukowski, Lee S. Schwartzberg, Gregory A. Vidal, Teresa M. Waters, Andrew J. Paladino, Tameka N. Jones, Ryan Blue, M...> ;Health Communication. 2021 Sep 19
• Join now to see all

Lectures

• Risk stratification based on a prognostic factor index among patients with HR+, HER2- MBC. 
  2019 ASCO Annual Meeting - 6/1/2019